Purpose: evaluate of Piracetam effectiveness in the treatment of Non-arteritic anterior ischemic optic neuopathy. Methods: Research and clinical trials with control group, 60 patients with pieces of research in which 30 patients with Non-arteritic anterior ischemic optic neuropathy piracetam treatment and 30 patients with placebo treatment. Results: The group treated with piracetam average visual acuity, improving visual acuity, improving visual acuity percent, visual field, percentage improved result visual field are higher than the control group from time to time monitor default. Although no difference statistically significant.